Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDF) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 134,600 shares, a growth of 71.9% from the February 28th total of 78,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 2,000 shares, the short-interest ratio is currently 67.3 days.

Oxford Biomedica Price Performance

Shares of OTCMKTS:OXBDF remained flat at $3.88 during midday trading on Friday. The stock’s 50-day simple moving average is $4.49 and its two-hundred day simple moving average is $4.92. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a fifty-two week low of $2.44 and a fifty-two week high of $5.68.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.